Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
American Journal of Surgery
|
October 1, 1991
Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck
J Fontanesi, N S Beckford, E P Lester, et al.
Circulation
|
January 1, 1989
Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride
J L Witztum, D Simmons, D Steinberg, et al.
The American Journal of Medicine
|
May 1, 1978
Sepsis in treated Hodgkin's disease
E P Lester, R Chilcote, U Mintz, et al.
Environmental Science & Technology
|
September 22, 2015
Formation of Soluble Mercury Oxide Coatings: Transformation of Elemental Mercury in Soils
Carrie L Miller, David B Watson, Brian P Lester, et al.
Cancer
|
February 1, 1997
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center
I Athanasiadis, S Taylor, E E Vokes, et al.
Cancer Investigation
|
July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856
E P Lester, G R Petroni, M Barcos, et al.
Endocrinology
|
January 6, 2001
Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance
Y Dubaquié, D L Mortensen, A Intintoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis
P J Hesketh, W K Murphy, E P Lester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting
T M Beck, P J Hesketh, S Madajewicz, et al.
Cancer
|
July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment
U Mintz, J B Miller, H M Golomb, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
American Journal of Surgery
|
October 1, 1991
Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck
J Fontanesi, N S Beckford, E P Lester, et al.
Circulation
|
January 1, 1989
Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride
J L Witztum, D Simmons, D Steinberg, et al.
The American Journal of Medicine
|
May 1, 1978
Sepsis in treated Hodgkin's disease
E P Lester, R Chilcote, U Mintz, et al.
Environmental Science & Technology
|
September 22, 2015
Formation of Soluble Mercury Oxide Coatings: Transformation of Elemental Mercury in Soils
Carrie L Miller, David B Watson, Brian P Lester, et al.
Cancer
|
February 1, 1997
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center
I Athanasiadis, S Taylor, E E Vokes, et al.
Cancer Investigation
|
July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856
E P Lester, G R Petroni, M Barcos, et al.
Endocrinology
|
January 6, 2001
Binding protein-3-selective insulin-like growth factor I variants: engineering, biodistributions, and clearance
Y Dubaquié, D L Mortensen, A Intintoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis
P J Hesketh, W K Murphy, E P Lester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting
T M Beck, P J Hesketh, S Madajewicz, et al.
Cancer
|
July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment
U Mintz, J B Miller, H M Golomb, et al.
Page
of 11